{"id":"W2980534320","doi":"10.1200/jco.18.01967","title":"Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Janssen Pharmaceuticals; National Cancer Institute; Medical Research Council; Takeda Oncology; Canadian Cancer Society Research Institute; National Institutes of Health; Ipsen; Astellas Pharma; National Health and Medical Research Council; Cancer Research UK; National Institute for Health and Care Research; American College of Radiology Imaging Network; NRG Oncology; Bristol-Myers Squibb; National Cancer Research Institute; Cancer Research Institute; NIHR Cambridge Biomedical Research Centre; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Breast Cancer Research Foundation; Sanofi; Oncosuisse; Pfizer","keywords":"Exemestane; Medicine; Tamoxifen; Breast cancer; Internal medicine; Oncology; Gynecology; Estrogen receptor; Population; Adjuvant; Proportional hazards model; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008929772,0.0001796661,0.0008453351,0.00004275748,0.00002920037,0.00001349467,0.0002262522,0.0001618257,0.0000302243],"category_scores_gemma":[0.001276273,0.0001336586,0.0001119187,0.00004670373,0.0001048202,0.0000117784,0.0001839542,0.0002198922,0.000006303916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009718301,"about_ca_system_score_gemma":0.0002843875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002758774,"about_ca_topic_score_gemma":0.0006268548,"domain_scores_codex":[0.9975076,0.000139274,0.001481498,0.0004136118,0.0001555966,0.0003023728],"domain_scores_gemma":[0.9977,0.0008356246,0.0008636711,0.0002407764,0.0001762407,0.0001836889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.08268752,0.002764456,0.1799958,0.00003420808,0.002562616,0.00009155235,0.001828809,0.00007686685,0.1021434,0.00004401094,0.007528302,0.6202424],"study_design_scores_gemma":[0.03053428,0.02191378,0.6822555,0.0001272323,0.000121274,0.000008581755,0.0007220033,0.00004719594,0.001938073,0.001569393,0.2604285,0.0003341798],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931798,0.00144978,0.0002200829,0.002819564,0.00135343,0.0004409502,0.0004538826,0.000002695215,0.00007982601],"genre_scores_gemma":[0.992552,0.0007755526,0.004704142,0.0008987153,0.0008579532,0.00005387384,0.0000435972,0.00001620298,0.00009797909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6199082,"threshold_uncertainty_score":0.5450439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0424609352209686,"score_gpt":0.3827609241418298,"score_spread":0.3402999889208612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}